ILMN סך כל נכסי החברה Illumina Inc

Genome sequencing patents secure leadership for Illumina, Inc. (ILMN), although antitrust disputes and reorganization are currently weakening this moat. The company generates revenue through a "razor-and-blade" model, selling expensive equipment followed by the recurring supply of consumables. According to the price chart on GURU.Markets, total assets stand at 6494.92, supporting a business built on high-margin genetic analysis technologies and microchips.

Illumina, Inc. (ILMN) maintains a dominant position in the genetic sequencing and bioinformatics sectors. The asset level trend reflects the total value of all resources, calculated inversely via return on assets (ROA). This indicator measures the business's fundamental base, combining equity and liabilities. Amid geopolitical restrictions on the export of DNA technologies, the stability of this metric confirms the company's resilience to market disruptions.